Literature DB >> 31143573

Value of K i -67 Labeling Index in Predicting Recurrence of WHO Grade I Cranial Base Meningiomas.

Jose Gabrielle Matias1, Ignacio Jusue-Torres2, Brendan Martin3, Ankush Bajaj4, Ewa Borys5, Edward Melian6, Kevin Barton7, Douglas E Anderson2, Vikram C Prabhu2.   

Abstract

Objectives  Assess impact of K i -67 labeling index (LI; K i -67 LI) on risk of recurrence or progression of WHO grade I meningiomas. Study Design  Retrospective study of adult patients who underwent resection of cranial base meningioma between 2004 and 2016. Results  272 patients fulfilled criteria for inclusion in the study. Average age was 61.8 years; 196 (72%) were females. Simpson's grade 1 resection was noted in 77 patients (32%), grade 2 in 39 (16%), grade 3 in 36 (15%), and grade 4 in 88 (37%). The K i -67 LI was low (1-4%) in 214 (78.7%), intermediate (5-9%) in 44 (16.2%), and high (>10%) in 14 (5.2%). Median follow-up was 39 months (IQR: 16-71 months); 221 (87.1%) tumors remained stable or did not recur, 19 (7.4%) recurred, and 14 (5.5%) progressed. Compared with tumors with low K i -67 LI, those with intermediate K i -67 LI had 2.47 times (2.47 [1.09-5.59], p  = 0.03), and those with high K i -67 LI had 3.38 times (3.38 [1.16-9.89], p  = 0.03) higher risk of recurrence or progression. Tumors with K i -67 LI > 4% had a shorter time to recurrence or progression ( p  = 0.01). Recurrence or progression-free survival rates at 3, 5, and 10 years for tumors with low K i -67 LI were 95%, 89%, and 75%, respectively; tumors with intermediate K i -67 LI, 87%, 69%, and 52%, respectively; tumors with high K i -67 LI, 78%, 49%, and 49%, respectively. Conclusions  Following surgical resection of a WHO grade I cranial base meningioma, K i -67 LI > 4% may predict an increased risk of recurrence or progression of residual tumor.

Entities:  

Keywords:  K i -67 labeling index ; cranial base meningioma; meningioma; meningioma recurrence

Year:  2018        PMID: 31143573      PMCID: PMC6534743          DOI: 10.1055/s-0038-1669387

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  40 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells.

Authors:  S Bruno; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  1992-01       Impact factor: 6.831

Review 3.  Long term experience of gamma knife radiosurgery for benign skull base meningiomas.

Authors:  W Kreil; J Luggin; I Fuchs; V Weigl; S Eustacchio; G Papaefthymiou
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

4.  Intracranial meningiomas of childhood and adolescence.

Authors:  Kadir Tufan; Fikret Dogulu; Gokhan Kurt; Hakan Emmez; Necdet Ceviker; M Kemali Baykaner
Journal:  Pediatr Neurosurg       Date:  2005 Jan-Feb       Impact factor: 1.162

5.  Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis.

Authors:  J Ayerbe; R D Lobato; J de la Cruz; R Alday; J J Rivas; P A Gómez; A Cabrera
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

Review 6.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

7.  Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.

Authors:  Donald Ming-Tak Ho; Chih-Yi Hsu; Ling-Tan Ting; Hung Chiang
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

8.  Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.

Authors:  H Maier; D Ofner; A Hittmair; K Kitz; H Budka
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

9.  Large sphenoid wing meningiomas involving the cavernous sinus: conservative surgical strategies for better functional outcomes.

Authors:  Khaled M Abdel-Aziz; Sebastien C Froelich; Elias Dagnew; Walter Jean; John C Breneman; Mario Zuccarello; Harry R van Loveren; John M Tew
Journal:  Neurosurgery       Date:  2004-06       Impact factor: 4.654

10.  Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience.

Authors:  Andrea Pirzkall; Jürgen Debus; Peter Haering; Bernhard Rhein; Karl Heinz Grosser; Angelika Höss; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-02-01       Impact factor: 7.038

View more
  2 in total

1.  Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.

Authors:  Antonio Dono; Ankush Chandra; Leomar Y Ballester; Yoshua Esquenazi
Journal:  Neurosurgery       Date:  2021-06-15       Impact factor: 4.654

2.  Atypical Histological Features as Risk Factors for Recurrence in Newly Diagnosed WHO Grade I Meningioma.

Authors:  Keitaro Chiba; Takashi Sugawara; Daisuke Kobayashi; Akihito Sato; Yasuhiro Murota; Taketoshi Maehara
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-09-01       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.